Blay Eddie, Balogun Yetunde, Nooromid Michael J, Eskandari Mark K
Surgical Outcomes and Quality Improvement Center (SOQIC), Department of Surgery and Center for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, IL; Department of Surgery, Temple University Hospital, Philadelphia, PA.
Department of Surgery, Temple University Hospital, Philadelphia, PA.
Ann Vasc Surg. 2019 May;57:194-200. doi: 10.1016/j.avsg.2018.10.023. Epub 2019 Jan 26.
Recurrent ischemic events have been associated with delayed carotid endarterectomy (CEA) for patients who present with acute strokes. As such, earlier intervention has been advocated to preserve cerebral function and expedient rehabilitation. We sought to determine the differences in 30-day postoperative major adverse clinical events (MACEs) for patients who undergo early (≤7 days) and delayed (>7 days) CEA after acute stroke.
Our sample consisted of patients captured in the CEA-targeted American College of Surgeons National Surgical Quality Improvement Program data set between 2011 and 2015. The primary outcome was 30-day postoperative MACEs (death, stroke, or myocardial infarction [MI]). Differences in postoperative MACEs were determined between early and delayed CEA treatment. In addition, multivariable analyses were done to determine the association between various patient factors and postoperative complications after CEA for patients who presented with acute strokes.
A total of 3,427 patients were identified who underwent CEA for acute stroke in the CEA-targeted files between 2011 and 2015. Overall, perioperative rates of 30-day death, stroke, or MI were 1.30% (n = 43), 2.74% (n = 94), and 0.96% (n = 33), respectively. There were no differences in 30-day postoperative death, stroke, or MI for early or delayed CEA after acute strokes. On multivariable analysis, independent predictors for postoperative MACEs in patients with acute stroke were age ≥80 years (OR 2.41; 95% CI [1.15-5.06]), preoperative beta-blocker use (OR 2.11; 95% CI [1.13-3.93]), and operative time > 150 min (OR 2.39; 95% CI [0.82-4.98]).
There are no differences in postoperative 30-day death, stroke, or MI in early and delayed CEA after an acute stroke. These results substantiate the recommendation for early (<7 days) CEA after acute strokes.
对于急性卒中患者,复发性缺血事件与延迟行颈动脉内膜切除术(CEA)有关。因此,提倡早期干预以保护脑功能并促进康复。我们试图确定急性卒中后接受早期(≤7天)和延迟(>7天)CEA治疗的患者术后30天主要不良临床事件(MACE)的差异。
我们的样本包括2011年至2015年期间纳入以CEA为目标的美国外科医师学会国家外科质量改进计划数据集中的患者。主要结局是术后30天的MACE(死亡、卒中或心肌梗死[MI])。确定早期和延迟CEA治疗术后MACE的差异。此外,进行多变量分析以确定急性卒中患者接受CEA治疗后各种患者因素与术后并发症之间的关联。
在2011年至2015年期间以CEA为目标的档案中,共识别出3427例因急性卒中接受CEA治疗的患者。总体而言,术后30天死亡、卒中或MI的发生率分别为1.30%(n = 43)、2.74%(n = 94)和0.96%(n = 33)。急性卒中后早期或延迟CEA治疗术后30天死亡、卒中或MI无差异。多变量分析显示,急性卒中患者术后MACE的独立预测因素为年龄≥80岁(OR 2.41;95%CI[1.15 - 5.06])、术前使用β受体阻滞剂(OR 2.11;95%CI[1.13 - 3.93])和手术时间>150分钟(OR 2.39;95%CI[0.82 - 4.98])。
急性卒中后早期和延迟CEA治疗术后30天死亡、卒中或MI无差异。这些结果证实了急性卒中后早期(<7天)行CEA的建议。